SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-20-000092
Filing Date
2020-05-28
Accepted
2020-05-28 19:35:37
Documents
3
Period of Report
2020-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_159070891807993.html 3  
1 FORM 3 wf-form3_159070891807993.xml 3 4155
2 POWER OF ATTORNEY smithpoa.htm EX-24 5143
3 POWER OF ATTORNEY GRAPHIC smithpoa001.jpg GRAPHIC 244072
  Complete submission text file 0001367644-20-000092.txt   346962
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAZZ PHARMACEUTICALS PLC 5TH FL, WATERLOO EXCHANGE, WATERLOO RD DUBLIN L2 4 L2
Business Address
Smith Karen L. (Reporting) CIK: 0001639637 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 20923413